Manchester Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Manchester Capital Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$239K	Buy	1,512 +110	+8%	+$14.9K	0.03%	258
2026 Q1	$179K	Hold	1,402	–	–	0.03%	285
2025 Q4	$171K	Buy	+1,402	New	+$161K	0.02%	289
2025 Q3	–	Sell	-128	Closed	-$10.6K	–	1345
2025 Q2	$10.6K	Sell	128 -1,490	-92%	-$119K	﹤0.01%	814
2025 Q1	$131K	Hold	1,618	–	–	0.02%	395
2024 Q4	$146K	Hold	1,618	–	–	0.02%	386
2024 Q3	$160K	Buy	1,618 +128	+9%	+$12.6K	0.02%	366
2024 Q2	$138K	Hold	1,490	–	–	0.02%	375
2024 Q1	$141K	Hold	1,490	–	–	0.02%	360
2023 Q4	$133K	Hold	1,490	–	–	0.02%	331
2023 Q3	$109K	Hold	1,490	–	–	0.02%	345
2023 Q2	$124K	Buy	+1,490	New	+$125K	0.02%	325
2021 Q1	–	Sell	-40	Closed	-$6K	–	803
2020 Q4	$6K	Hold	40	–	–	﹤0.01%	525
2020 Q3	$4K	Hold	40	–	–	﹤0.01%	459
2020 Q2	$4K	Hold	40	–	–	﹤0.01%	516
2020 Q1	$3K	Hold	40	–	–	﹤0.01%	512
2019 Q4	$4K	Hold	40	–	–	﹤0.01%	495
2019 Q3	$3K	Hold	40	–	–	﹤0.01%	497
2019 Q2	$4K	Hold	40	–	–	﹤0.01%	527
2019 Q1	$4K	Sell	40 -40	-50%	-$3.4K	﹤0.01%	613
2018 Q4	$8K	Hold	80	–	–	﹤0.01%	477
2018 Q3	$8K	Hold	80	–	–	﹤0.01%	486
2018 Q2	$8K	Buy	+80	New	+$7.35K	﹤0.01%	491
2015 Q1	–	Sell	-546	Closed	-$34K	–	910
2014 Q4	$34K	Hold	546	–	–	﹤0.01%	798
2014 Q3	$28K	Hold	546	–	–	﹤0.01%	836
2014 Q2	$28K	Hold	546	–	–	﹤0.01%	809
2014 Q1	$26K	Hold	546	–	–	﹤0.01%	734
2013 Q4	$24K	Sell	546 -900	-62%	-$37.3K	﹤0.01%	707
2013 Q3	$62K	Hold	1,446	–	–	0.01%	554
2013 Q2	$50K	Buy	+1,446	New	+$50.8K	0.01%	602

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Manchester Capital Management's XBI Position: Q2 2026 in Review

Manchester Capital Management increased its State Street SPDR S&P Biotech ETF (XBI) stake by 7.8% in Q2 2026, buying an estimated $14.9K and bringing the position to 1,512 shares worth $239K. The position accounts for 0.03% of the portfolio, ranked #258.

Manchester Capital Management first reported a position in XBI in Q2 2013 and has held it in 30 quarters since. 934 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Manchester Capital Management held 1,512 shares of State Street SPDR S&P Biotech ETF worth $239K as of Q2 2026.
Manchester Capital Management bought 110 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $14.9K.
State Street SPDR S&P Biotech ETF made up 0.03% of Manchester Capital Management's portfolio in Q2 2026, its #258 holding.
Manchester Capital Management first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 30 quarters since.
934 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Manchester Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.